Revealing common differential mRNAs, signaling pathways, and immune cells in blood, glomeruli, and tubulointerstitium of lupus nephritis patients based on transcriptomic data

References

• Anders HJ, Saxena R, Zhao MH, et al. Lupus nephritis. Nat Rev Dis Primers. 2020;6(1):1.
   PubMed Web of Science ®Google Scholar
• Ocampo-Piraquive V, Nieto-Aristizábal I, Cañas CA, et al. Mortality in systemic lupus erythematosus: causes, predictors and interventions. Expert Rev Clin Immunol. 2018;14(12):1043–11.
   PubMed Web of Science ®Google Scholar
• Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clin J Am Soc Nephrol. 2017;12(5):825–835.
   PubMed Web of Science ®Google Scholar
• Fanouriakis A, Kostopoulou M, Cheema K, et al. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis. 2020;79(6):713–723.
   PubMed Web of Science ®Google Scholar
• Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736–745.
   PubMed Web of Science ®Google Scholar
• Gasparotto M, Gatto M, Binda V, et al. Lupus nephritis: clinical presentations and outcomes in the 21st century. Rheumatology. 2020;59(Suppl. 5):v39–v51.
   PubMedGoogle Scholar
• Arazi A, Rao DA, Berthier CC, et al. The immune cell landscape in kidneys of patients with lupus nephritis. Nat Immunol. 2019;20(7):902–914.
   PubMed Web of Science ®Google Scholar
• Yap DYH, Chan TM. B cell abnormalities in systemic lupus erythematosus and lupus nephritis—role in pathogenesis and effect of immunosuppressive treatments. Int J Mol Sci. 2019;20(24):6231.
   PubMed Web of Science ®Google Scholar
• Yoshida N, He F, Kyttaris VC. T cell-specific STAT3 deficiency abrogates lupus nephritis. Lupus. 2019;28(12):1468–1472.
   PubMed Web of Science ®Google Scholar
• Lech M, Anders HJ. The pathogenesis of lupus nephritis. J Am Soc Nephrol. 2013;24(9):1357–1366.
   PubMed Web of Science ®Google Scholar
• Ye X, Wang Z, Ye Q, et al. High-throughput sequencing-based analysis of T cell repertoire in lupus nephritis. Front Immunol. 2020;11:1618.
   PubMed Web of Science ®Google Scholar
• Fayed A, Mohamed A, Ahmed RA, et al. Evaluation of urinary FOXP3 mRNA as a biomarker of lupus nephritis in Egyptian patients with systemic lupus erythematosus. Lupus. 2021;30(10):1631–1636.
   PubMed Web of Science ®Google Scholar
• Mao YJ, Qin S, Jiao ZF. Wnt pathway regulates IL-34 level in lupus nephritis. Eur Rev Med Pharmacol Sci. 2019;23(12):5360–5365.
   PubMed Web of Science ®Google Scholar
• Wang XD, Huang XF, Yan QR, et al. Aberrant activation of the WNT/β-catenin signaling pathway in lupus nephritis. PLOS One. 2014;9(1):e84852.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huang X, Liu J, et al. New insight into long non-coding RNAs associated with bone metastasis of breast cancer based on an integrated analysis. Cancer Cell Int. 2021;21(1):372.
   PubMed Web of Science ®Google Scholar
• Wu H, Jia B, Zhao X, et al. Pathophysiology and system biology of rat c-BSA induced immune complex glomerulonephritis and pathway comparison with human gene sequencing data. Int Immunopharmacol. 2022;109:108891.
   PubMedGoogle Scholar
• Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28(1):27–30.
   PubMed Web of Science ®Google Scholar
• Dittrich T, Marsch S, Egli A, et al. Predictors of infectious meningitis or encephalitis: the yield of cerebrospinal fluid in a cross-sectional study. BMC Infect Dis. 2020;20(1):304.
   PubMed Web of Science ®Google Scholar
• Šimundić AM. Measures of diagnostic accuracy: basic definitions. EJIFCC. 2009;19(4):203–211.
   PubMedGoogle Scholar
• Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18(1):220.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(–delta delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Shimizu Y, Yasuda S, Kimura T, et al. Interferon-inducible Mx1 protein is highly expressed in renal tissues from treatment-naïve lupus nephritis, but not in those under immunosuppressive treatment. Mod Rheumatol. 2018;28(4):661–669.
   PubMed Web of Science ®Google Scholar
• Watanabe S, Imaizumi T, Tsuruga K, et al. Glomerular expression of myxovirus resistance protein 1 in human mesangial cells: possible activation of innate immunity in the pathogenesis of lupus nephritis. Nephrology. 2013;18(12):833–837.
   PubMed Web of Science ®Google Scholar
• Qing J, Song W, Tian L, et al. Potential small molecules for therapy of lupus nephritis based on genetic effect and immune infiltration. Biomed Res Int. 2022;2022:2259164.
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhang L, Wang J, et al. Identification of key biomarkers and immune infiltration in systemic lupus erythematosus by integrated bioinformatics analysis. J Transl Med. 2021;19(1):35.
   PubMed Web of Science ®Google Scholar
• Siddiqi KZ, Wilhelm TR, Ulff-Møller CJ, et al. Cluster of highly expressed interferon-stimulated genes associate more with African ancestry than disease activity in patients with systemic lupus erythematosus. A systematic review of cross-sectional studies. Transl Res. 2021;238:63–75.
   PubMed Web of Science ®Google Scholar
• Coit P, Jeffries M, Altorok N, et al. Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naïve CD4+ T cells from lupus patients. J Autoimmun. 2013;43:78–84.
   PubMed Web of Science ®Google Scholar
• Mitwalli AH, Hayat A, Alwakeel J, et al. Effects of concomitant hepatitis C virus infection in patients with underlying lupus nephritis on long-term renal outcome. Nephrol Dial Transplant. 2012;27(2):627–632.
   PubMed Web of Science ®Google Scholar
• Nakamura H, Fujieda Y, Yasuda S, et al. Remission of nephrotic syndrome after therapy for chronic hepatitis C virus infection in a patient with systemic lupus erythematosus. Ann Intern Med. 2018;169(5):352–353.
   PubMed Web of Science ®Google Scholar
• Sim JJL, Lim CC. Influenza vaccination in systemic lupus erythematosus: efficacy, effectiveness, safety, utilization, and barriers. Am J Med. 2022;135(3):286–296.e9.
   PubMed Web of Science ®Google Scholar
• Crowe SR, Merrill JT, Vista ES, et al. Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features. Arthritis Rheum. 2011;63(8):2396–2406.
   PubMedGoogle Scholar
• Mejia-Vilet JM, Zhang XL, Cruz C, et al. Urinary soluble CD163: a novel noninvasive biomarker of activity for lupus nephritis. J Am Soc Nephrol. 2020;31(6):1335–1347.
   PubMed Web of Science ®Google Scholar
• Gupta R, Yadav A, Aggarwal A. Urinary soluble CD163 is a good biomarker for renal disease activity in lupus nephritis. Clin Rheumatol. 2021;40(3):941–948.
   PubMed Web of Science ®Google Scholar
• Shen L, Lan L, Zhu T, et al. Identification and validation of IFI44 as key biomarker in lupus nephritis. Front Med. 2021;8:762848.
   Web of Science ®Google Scholar
• Coit P, Renauer P, Jeffries MA, et al. Renal involvement in lupus is characterized by unique DNA methylation changes in naïve CD4+ T cells. J Autoimmun. 2015;61:29–35.
   PubMed Web of Science ®Google Scholar
• Antunes Andrade F, Goeldner Eibofner I, Pieczarka C, et al. Impact of VSIG4 gene polymorphisms on susceptibility and functional status of rheumatoid arthritis. Int J Immunogenet. 2021;48(3):260–265.
   PubMed Web of Science ®Google Scholar
• He JQ, Wiesmann C, van Lookeren Campagne M. A role of macrophage complement receptor CRIg in immune clearance and inflammation. Mol Immunol. 2008;45(16):4041–4047.
   PubMed Web of Science ®Google Scholar
• Shi Y, Yao W, Sun L, et al. The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice. BMC Nephrol. 2019;20(1):424.
   PubMed Web of Science ®Google Scholar
• Lieberman LA, Mizui M, Nalbandian A, et al. Complement receptor of the immunoglobulin superfamily reduces murine lupus nephritis and cutaneous disease. Clin Immunol. 2015;160(2):286–291.
   PubMed Web of Science ®Google Scholar
• Cao Y, Tang W, Tang W. Immune cell infiltration characteristics and related core genes in lupus nephritis: results from bioinformatic analysis. BMC Immunol. 2019;20(1):37.
   PubMed Web of Science ®Google Scholar
• Zhang LJ, Yan C, Schouteden S, et al. The impact of integrin β2 on granulocyte/macrophage progenitor proliferation. Stem Cells. 2019;37(3):430–440.
   PubMed Web of Science ®Google Scholar
• Li Q, Zhang P, Yu X, et al. Lead transiently promotes granulocyte-macrophage progenitor differentiation and subsequently suppresses common myeloid progenitor differentiation. Toxicol Sci. 2017;160(2):268–283.
   PubMed Web of Science ®Google Scholar
• Wang W, Lin Z, Feng J, et al. Identification of ferroptosis-related molecular markers in glomeruli and tubulointerstitium of lupus nephritis. Lupus. 2022;31(8):985–997.
   PubMed Web of Science ®Google Scholar
• Fan H, Dong G, Zhao G, et al. Gender differences of B cell signature in healthy subjects underlie disparities in incidence and course of SLE related to estrogen. J Immunol Res. 2014;2014:814598.
   PubMed Web of Science ®Google Scholar